Alessandro De Vita, Silvia Vanni, Valentina Fausti, Claudia Cocchi, Federica Recine, Giacomo Miserocchi, Chiara Liverani, Chiara Spadazzi, Massimo Bassi, Manlio Gessaroli, Angelo Campobassi, Giovanni De Luca, Federica Pieri, Anna Farnedi, Eugenia Franchini, Anna Ferrari, Chiara Domizio, Enrico Cavagna, Lorena Gurrieri, Alberto Bongiovanni, Nada Riva, Sebastiano Calpona, Giandomenico Di Menna, Silvia Angela Debonis, Toni Ibrahim, Laura Mercatali
Adult rhabdomyosarcoma (RMS) represents an uncommon entity with an incidence of less than 3% of all soft tissue sarcomas (STS). Consequently, the natural history and the clinical management of this disease are infrequently reported. In order to fill this gap, we investigated the molecular biology of an adult RMS case series. The expression of epithelial mesenchymal transition-related gene and chemoresistance-related gene panels were evaluated. Moreover, taking advantage of our STS translational model combining patient-derived primary culture and 3D-scaffold, the pharmacological profile of an adult head and neck sclerosing RMS was assessed...
October 26, 2021: International Journal of Molecular Sciences